Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
ASH 2023 Insights: "HR-QOL in Adults With Hemophilia B Treated With Fidanacogene Elaparvovec Gene Therapy"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Sylvia Mackensen
By
Insights from 2023 ASH Annual Meeting
FEATURING
Sylvia Mackensen
34 views
January 16, 2024
Comments 0
Login to view comments.
Click here to Login
Benign Hematology